In Reply: Dr Hoffman and colleagues suggest that uncertainties in dose estimation were not adequately accounted for in the HTDS1 and that the failure to detect increased risk of thyroid disease may be due to methodologic problems. They also question my summary of the evidence on the relationship between iodine 131 and thyroid disease, and the contribution of shorter-lived radioiodines to thyroid dose following the Chernobyl disaster.